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by autocrine TNF.
Cell Reports
ArticleCYLD Proteolysis Protects Macrophages
from TNF-Mediated Auto-necroptosis Induced
by LPS and Licensed by Type I IFN
Diana Legarda,1,10 Scott J. Justus,1,2,10 Rosalind L. Ang,1 Nimisha Rikhi,1 Wenjing Li,3,4 Thomas M. Moran,1,3,4
Jianke Zhang,5 Emiko Mizoguchi,6,7 Matija Zelic,8 Michelle A. Kelliher,8 J. Magarian Blander,1,2,3,9 and Adrian T. Ting1,2,9,*
1Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Graduate School of Biological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
3Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
4Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
5Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
6Department of Medicine, Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114, USA
7Department of Medicine, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, MA 02114, USA
8Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA
9Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
10Co-first author
*Correspondence: adrian.ting@mssm.edu
http://dx.doi.org/10.1016/j.celrep.2016.05.032SUMMARY
Tumor necrosis factor (TNF) induces necroptosis, a
RIPK3/MLKL-dependent form of inflammatory cell
death. In response to infection by Gram-negative
bacteria, multiple receptors on macrophages,
including TLR4, TNF, and type I IFN receptors, are
concurrently activated, but it is unclear how they
crosstalk to regulate necroptosis. We report that
TLR4 activates CASPASE-8 to cleave and remove
the deubiquitinase cylindromatosis (CYLD) in a
TRIF- and RIPK1-dependent manner to disable nec-
roptosis in macrophages. Inhibiting CASPASE-8
leads to CYLD-dependent necroptosis caused by
the TNF produced in response to TLR4 ligation.While
lipopolysaccharides (LPS)-induced necroptosis was
abrogated in Tnf/ macrophages, a soluble TNF
antagonist was not able to do so in Tnf+/+ macro-
phages, indicating that necroptosis occurs in a cell-
autonomous manner. Surprisingly, TNF-mediated
auto-necroptosis of macrophages requires type I
IFN, which primes the expression of key nec-
roptosis-signaling molecules, including TNFR2 and
MLKL. Thus, the TNF necroptosis pathway is regu-
lated by both negative and positive crosstalk.INTRODUCTION
Multiple forms of programmed cell death occur followingmicro-
bial infection, serving to eliminate infected cells and to mount
an appropriate host response (Campisi et al., 2014; Vanden
Berghe et al., 2014). Apoptosis, which is predominantly depen-Cell
This is an open access article unddent on effector caspases such as CASPASE-3 and -7, is
thought to generate a tolerogenic response if it occurs in the
absence of an inflammatory signal. Pyroptosis, which is depen-
dent on CASPASE-1 and -11, occurs following activation of the
inflammasome by microbial products. Pyroptosis serves to
eradicate infected cells and the release of cellular contents
and damage-associated molecular patterns (DAMPs) following
plasma membrane permeabilization amplifies the inflammatory
response (Bergsbaken et al., 2009; Chen and Nun˜ez, 2010). In
contrast to apoptosis and pyroptosis, which are dependent
on various caspases, necroptosis or programmed necrosis
has recently emerged as a form of cell death that occurs in
the absence of caspase activity. Similar to pyroptosis, necrop-
tosis is also characterized by plasma membrane permeabiliza-
tion with the release of DAMPs and thus also induces a pro-in-
flammatory response. Necroptosis may allow the host to
circumvent the blockade of caspase-dependent death path-
ways that may be imposed by a pathogen that encodes cas-
pase inhibitors to block apoptosis or pyroptosis and to retain
the ability to mount an inflammatory response to signal danger
(Chan et al., 2003; Mocarski et al., 2011; Upton et al., 2010). In
this regard, inhibition of host caspases by pathogens and sub-
sequent induction of necroptosis functions effectively as a
pathogen-sensing event.
One of the best-characterized inducers of necroptotic death
is the cytokine tumor necrosis factor (TNF), which paradoxi-
cally, can also induce a cell survival response within the
same cell. Which response is generated is dependent on the
ubiquitination status of the signaling molecule RIPK1 following
ligation of TNF receptor 1 (TNFR1); non-degradative Lys63-
linked ubiquitination of RIPK1 leads to cell survival whereas in-
hibiting ubiquitination of RIPK1 leads to necroptosis (Justus
and Ting, 2015). In some cellular models, blocking ubiquitina-
tion (often using SMAC mimetics) causes RIPK1 to first initiate
a caspase-signaling cascade leading to apoptosis (O’DonnellReports 15, 2449–2461, June 14, 2016 ª 2016 The Author(s). 2449
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
et al., 2007; Wang et al., 2008), but if caspases are also
blocked (often using zVAD-fmk), then RIPK1 initiates necrop-
tosis (He et al., 2009; O’Donnell et al., 2011). In other cellular
models, blocking caspases is sufficient to trigger necroptosis
in the presence of TNF (O’Donnell et al., 2011). In the latter
models, the fact that a caspase inhibitor switches the TNF
response from survival to necroptosis indicates that a caspase
normally generates a pro-survival signal. When that survival
signal is blocked, necroptosis is switched on. The molecular
mechanism underlying this survival versus necroptosis switch
has been clarified over the last few years. Following TNFR1
ligation, CASPASE-8, in a complex with FADD and c-FLIP,
delivers a pro-survival signal (Dillon et al., 2012) by cleaving
and removing the tumor suppressor cylindromatosis (CYLD)
(O’Donnell et al., 2011). CYLD is a deubiquitinating enzyme
that is essential for TNF-induced necroptosis (Hitomi et al.,
2008; O’Donnell et al., 2011; Vanlangenakker et al., 2010). It
disassembles Lys63-linked ubiquitination from RIPK1, a requi-
site step for necroptosis. Removal of CYLD by CASPASE-8
sustains the ubiquitination of RIPK1, leading to a survival
response. Thus, the CASPASE-8:CYLD interaction is an early
switch that determines survival versus necroptotic death in
the TNFR1 pathway.
With the discovery of RIPK3 as an essential molecule in TNF-
induced necroptosis (Cho et al., 2009; He et al., 2009; Zhang
et al., 2009), the physiological and patho-physiological roles
of necroptosis are starting to become clearer. Excessive
RIPK3-dependent necroptosis, often revealed by the genetic
deletion of CASPASE-8, leads to embryonic lethality (Kaiser
et al., 2011; Oberst et al., 2011), mucosal inflammation (G€unther
et al., 2011; Welz et al., 2011), and an impaired T cell response
(Ch’en et al., 2011). Furthermore, RIPK3-dependent necropto-
sis has been reported to be beneficial as well as detrimental
for the host during bacterial and viral infections (Cho et al.,
2009; Duprez et al., 2011; Polykratis et al., 2014; Robinson
et al., 2012; Upton et al., 2010). These in vivo studies indicated
that RIPK3-dependent necroptosis is activated subsequent to
an interaction between the pathogen and the host’s path-
ogen-sensing innate cells. Following recognition of lipopolysac-
charides (LPS) derived from Gram-negative bacteria by TLR4
on macrophages, a signature response is the production of
TNF. This cytokine is a potent inducer of necroptosis and yet
surprisingly, little is known about what effect auto-produced
TNF may have on necroptosis in macrophages. In addition to
TNF, TLR4 stimulation also leads to the production of type I
interferon (IFN) a and b. Type I IFN has also been reported to
trigger necroptosis (McComb et al., 2014a; Robinson et al.,
2012; Thapa et al., 2013) but whether type I IFN participates
in TNF-mediated necroptosis is unclear.
We report here that TLR4, via the TRIF signaling adaptor,
rapidly activates CASPASE-8 to cleave and remove CYLD.
This CASPASE-8-mediated cleavage event has a self-preser-
vation function because when it is blocked, macrophages un-
dergo auto-necroptosis caused by the TNF that is produced.
Furthermore, the ability of TNF to induce necroptosis in macro-
phages requires IFNa/b priming because in its absence, macro-
phages have defective expression of key necroptosis-signaling
molecules.2450 Cell Reports 15, 2449–2461, June 14, 2016RESULTS
TLR4 Activates CASPASE-8 to Eliminate the
Pro-necroptotic Molecule CYLD
We previously demonstrated that the deubiquitinating enzyme
CYLD is the key substrate cleaved by CASPASE-8 to
block TNF-mediated necroptosis (O’Donnell et al., 2011). Upon
TNFR1 ligation, CYLD is cleaved by CASPASE-8 at aspartate
215, resulting in the generation of a N-terminal 25 kDa fragment
and degradation of the C-terminal fragment containing the
catalytic domain (O’Donnell et al., 2011). Because TNF is pro-
duced in response to LPSduring bacterial infection, we surmised
that TNF would activate CASPASE-8 in an autocrine manner to
cleave CYLD. Loss of CYLD would then prevent necroptosis
and sustain cell survival. Therefore, we sought to confirm that
CASPASE-8-mediated cleavage of CYLD occurs after TLR4
ligation. When wild-type bone marrow-derived macrophages
(BMDMs) were stimulated with LPS, levels of the 107 kDa full-
length CYLD (p107) decreased in a time- and dose-dependent
manner, coinciding with the appearance of the 25 kDa CYLD
fragment (p25) generated by CASPASE-8-mediated cleavage
(Figures 1A and 1B). This cleavage fragment was evident as early
as 30 min, implying that CASPASE-8 activity is rapidly induced.
This is due to TLR4 as it was not observed in Tlr4/ BMDMs
(Figure S1A). The ability of other TLR ligands to induce CYLD
cleavage was also tested and only TLR3 and TLR4 ligands could
do so after a 4 hr stimulation (Figure S1B). Infection of BMDMs
with two Gram-negative bacteria, Escherichia coli strain LF82
and Citrobacter rodentium, similarly resulted in the proteolytic
processing of CYLD (Figure 1C). Cleavage of CYLD was in-
hibited by the pan-caspase inhibitor z-VAD-fmk (Figure S1C),
indicating that this is dependent on the proteolytic activity
of caspases. Similar to murine BMDMs, stimulation of the
human monocytic cell line THP-1 with LPS also resulted in cas-
pase-dependent cleavage of CYLD (Figure S1D). To confirm
that the FADD/CASPASE-8 complex cleaves CYLD in macro-
phages, we compared BMDMs from Ripk3/Casp8/ or
Ripk3/Fadd/mice toRipk3/mice since theRipk3 deletion
rescued the embryonic lethality of the Casp8/ and Fadd/
single knockout mice (Dillon et al., 2012; Kaiser et al., 2011;
Oberst et al., 2011). The appearance of the CYLD p25 fragment
following LPS stimulation and bacterial infection was detected in
Ripk3/ BMDMs, but not in Casp8/Ripk3/ (Figure 1D) or
Fadd/Ripk3/ BMDMs (Figure S1E). Thus, the FADD/CAS-
PASE-8 complex rapidly cleaves CYLD after TLR4 stimulation.
TLR4-TRIF Signaling and Not TNF Mediates
CASPASE-8-Dependent Cleavage of CYLD
As discussed earlier, our expectation was that LPS-induced
cleavage of CYLD would be dependent on auto-production of
TNF, which we sought to confirm using Tnf knockout BMDMs.
Surprisingly, the cleavage of CYLD was not dependent on TNF
since it was observed in both Tnf+/+ and Tnf/BMDMs following
LPS stimulation (Figure 2A). To test the possibility that the
CASPASE-8-mediated cleavage of CYLD may be secondary
to another cytokine produced, we pre-treated BMDMs with
the protein synthesis inhibitor cycloheximide prior to LPS
stimulation. Cycloheximide did not block CYLD cleavage and
Figure 1. TLR4 Activates CASPASE-8 to
Eliminate CYLD
(A and B) BMDMs from wild-type mice were
treated with 100 ng/ml of LPS for the indicated
times (A) or with the indicated concentrations of
LPS for 4 hr (B).
(C) BMDMs from wild-type BMDMs were infected
with viable E. coli or C. rodentium for 4 hr.
(D) BMDMs from wild-type, Ripk3/, and
Ripk3/Casp8/ mice were stimulated with
either LPS (100 ng/ml), E. coli (MOI 1), or
C. rodentium (MOI 1) for the indicated times. Ly-
sates were subject to western blot analysis using
CYLD (D1A10), RIPK3, CASPASE-8, and GAPDH
antibodies. All experiments shown are represen-
tative of at least three independent experiments
with similar results.degradation, whereas it efficiently blocked the re-synthesis of
IkBa following LPS stimulation (Figure S2A). Therefore, cleavage
of CYLD by CASPASE-8 following TLR4 stimulation is indepen-
dent of de novo protein synthesis. This suggested a direct acti-
vation of CASPASE-8 by TLR4, prompting us to examine the
involvement of MYD88 and TRIF. Cleavage of CYLD induced
by TLR4 stimulation was not affected in the Myd88/ BMDMs
(Figure 2B), but was abrogated in the Trif/BMDMs (Figure 2C),
indicating that CASPASE-8 activation was dependent on TRIF.
Consistent with the requirement for TRIF in the activation of
CASPASE-8, the two molecules are able to form a complex
when co-expressed in HEK293 cells (Figure S2B). Thus, TLR4
activates CASPASE-8 in a TRIF-dependent but MYD88-inde-
pendent manner to eliminate CYLD and not via autocrine pro-
duction of cytokines.
Because the TNF signaling adaptor RIPK1 has been previously
implicated in TLR4 signaling (Cusson-Hermance et al., 2005;
Meylan et al., 2004) and RIPK1 and CASPASE-8 can associate
(Lin et al., 1999), we askedwhether RIPK1 has a role in regulatingCell Rthe activation of CASPASE-8 down-
stream of TLR4. Treatment with the
RIPK1 kinase inhibitor Necrostatin-1 prior
to LPS stimulation did not inhibit the
cleavage of CYLD in BMDMs (Figure 2D),
suggesting that the kinase activity of
RIPK1 is not required. However, RIPK1
could still regulate the function of
CASPASE-8 through a kinase-inde-
pendent mechanism. We utilized im-
mortalized BMDMs generated from
RosaCreERT2Ripk1fl/fl mice and treated
those cells with tamoxifen (4-OHT) to
acutely delete Ripk1 (Roderick et al.,
2014). LPS-induced cleavage of CYLD
was abrogated in the RIPK1-deficient
macrophages, demonstrating that this is
dependent on RIPK1 (Figure 2E). This de-
pendency on RIPK1 for CYLD cleavage
may be related to the reduced level of
CASPASE-8 observed in RIPK1-deficient
BMDMs suggesting that RIPK1 regulates CASPASE-8 expres-
sion in macrophages via a mechanism that is unclear at this
point.
TLR4 Induces Auto-necroptosis in Macrophages via
Production of TNF
It was reported that blocking caspase activity in LPS-stimulated
murine macrophages resulted in necroptosis (He et al., 2011;
Kaiser et al., 2013). Similarly, human THP-1 cells undergo nec-
roptosis when stimulated with LPS in the presence of zVAD-
fmk (Figure S2C). Although auto-produced TNF is not required
for CASPASE-8 to cleave CYLD following TLR4 stimulation (Fig-
ure 2A), whether auto-produced TNF is required for necroptosis
once CASPASE-8 is blocked remains questionable. Previous
studies have suggested that TLR4 induces necroptosis inde-
pendently of TNF after examining the response of Tnf/ or
Tnfr1/Tnfr2/ double knockout macrophages to high doses
of LPS (He et al., 2011; Kaiser et al., 2013). In light of the possi-
bility that the effect of a genetic deficiency in a Toll-like receptoreports 15, 2449–2461, June 14, 2016 2451
Figure 2. TLR4-TRIF Signaling and Not TNF Mediates CASPASE-8-
Dependent Cleavage of CYLD
(A) Wild-type and Tnf/ BMDMs were treated with 100 ng/ml of LPS for 4 hr.
(B and C)Wild-type,Myd88/, and Trif/BMDMswere treated with 10 ng/ml
of LPS for the indicated times.
(D) Wild-type BMDMs were pre-treated with 30 mM Necrostatin-1 prior to
stimulation with LPS for 4 hr.
(E) Immortalized BMDMs generated from RosaCreERT2Ripk1fl/fl mice were
treatedwith ethanol or with tamoxifen (4-OHT) to delete RIPK1. Cells were then
2452 Cell Reports 15, 2449–2461, June 14, 2016signaling molecule can be overlooked due to the use of high
amount of the ligand (Bonham et al., 2014; Horng et al., 2002),
we conducted our experiments using a lower range of LPS.
BMDMs from Tnf+/+ and Tnf/ mice were stimulated with vary-
ing concentrations of LPS up to 1 ng/ml for 16 hr. Under these
conditions, LPS alone did not induce cell death in wild-type
BMDMs whereas in the presence of zVAD-fmk, 1 ng/ml of LPS
was sufficient to achieve near maximal death of BMDMs (Fig-
ure 3A), a concentration that is 20- to 500-fold lower than that
used previously (He et al., 2011; Kaiser et al., 2013). Using this
lower range of LPS, necroptosis was abrogated in the Tnf/
BMDMs (Figure 3A). When we increased the concentration of
LPS by up to 100-fold more, the requirement for TNF was dimin-
ished even though there was still a difference in viability between
Tnf+/+ and Tnf/ macrophages (Figure S3A). Thus, at lower
doses of LPS, there is a strong dependency on TNF to induce
necroptosis whereas at higher doses, there is diminished depen-
dency. Similar to LPS, E. coli and C. rodentium infection at a low
MOI resulted in necroptosis that is dependent onTNF (Figure 3B).
The LPS or bacterial-induced necroptosis in wild-type BMDMs
was also inhibited by Necrostatin-1 (Nec-1), indicating a RIPK1
kinase dependency (Figures S3B and S3C). These results
demonstrate that Gram-negative bacteria, as well as stimulation
with limiting doses of LPS, induce necroptosis that is dependent
on autocrine production of TNF.
To further confirm the role of autocrine TNF, we examined the
role of MYD88 because this TLR signaling adaptor protein is
required for TNF production in response to LPS (Kawai et al.,
1999). Myd88+/+ BMDMs succumbed to necroptosis when
treated with LPS or infected with bacteria whereas Myd88/
BMDMs survived (Figure S3D). This result is consistent with
the fact that LPS-induced TNF expression is MYD88-dependent
(Kawai et al., 1999) and that remains true under necroptotic
conditions (Figure S3E). Because the other TLR4 signaling
adaptor TRIF has been implicated in TLR3- and TLR4-induced
necroptosis (He et al., 2011; Kaiser et al., 2013; McComb
et al., 2014a), we also examined whether TRIF is required for
necroptosis in our low-dose LPS model. Trif/ BMDMs were
more resistant to necroptosis in response to LPS or bacterial
infection (Figure S3F). The observation that TLR4-induced nec-
roptosis requires TNF (Figure 3A), as well as TRIF (Figure S3F),
was somewhat puzzling because TNF is not known to signal
through TRIF. In addition to its well-known role in the induction
of type IFN, TRIF also has a less appreciated role in TNF produc-
tion as suggested by a previous report (Gais et al., 2010). We
therefore considered the possibility that TNF expression may
be compromised in the TRIF-deficient BMDMs, which could pro-
vide one explanation for why they are more resistant to necrop-
tosis. Consistent with this possibility, TNF expression after LPS
stimulation was defective in the TRIF-deficient BMDMs, regard-
less of the absence or presence of zVAD-fmk (Figure S3G).
In addition to using the Tnf and Myd88 knockouts to demon-
strate a requirement for TNF in inducing necroptosis followingtreated with 100 ng/ml of LPS for the indicated times. Lysates were blotted as
indicated. All experiments shown are representative of at least three inde-
pendent experiments with similar results.
Figure 3. TLR4 Induces Auto-necroptosis in
Macrophages via Production of TNF
(A and B) BMDMs from Tnf+/+ or Tnf/ mice were
pre-treatedwith 25 mMzVAD-fmk or DMSOprior to
stimulation with the indicated concentrations of
LPS (A) or infected with E. coli or C. rodentium at
the indicated MOI (B) for 16 hr. Cell death was
measured by propidium iodide staining. Data are
presented as the mean of three independent ex-
periments performed in triplicate ± SD. Statistics
were performed using t test. *p < 0.05, **p < 0.01,
***p < 0.001.
(C) Wild-type BMDMs were treated with control-
FC or TNFR1-FC, in addition to either LPS or TNF,
for 24 hr. Viability was determined by CellTiter-Glo
assays. Data are presented as the mean of
three independent experiments performed in trip-
licate ± SD.TLR4 ligation, we also utilized a soluble TNF antagonist to inhibit
necroptosis. We confirmed the effectiveness of the murine
TNFR1-Fc fusion as an antagonist, as it was able to fully block
necroptosis of BMDMs induced by the addition of exogenous
TNF (Figure 3C). Surprisingly, it had only a modest effect on nec-
roptosis induced by LPS (Figure 3C). Because the genetic dele-
tion of Tnf blocked necroptosis induced by LPS but the soluble
mTNFR1-Fc did not, this strongly suggests that death is not
dependent on secreted TNF. This observation suggests that
death mediated by TNF occurs in a cell-autonomous manner
as a consequence of a ligand-receptor interaction in an intracel-
lular compartment that is not accessible to the soluble mTNFR1-
Fc antagonist. We have termed this process auto-necroptosis.
Eliminating CYLD Protects Macrophages against
TLR4-Induced Auto-necroptosis
We previously showed that removal of CYLD by CASPASE-8
generates a survival response in MEFs but when this cleavage
event is inhibited, CYLD-dependent necroptosis ensues (O’Don-
nell et al., 2011). Removal of CYLD following TLR4 stimulation
(Figure 1) may serve a similar pro-survival and anti-necroptotic
function in macrophages. Therefore, we examined the functional
consequence of the loss of CYLD using BMDMs from control or
Cyld conditional knockout mice. These conditional knockout
mice were generated by crossing Cyldflox/flox mice, which con-Cell Rtains LoxP sites flanking exons 8 and 9,
with the LysM-Cre strain to selectively
delete CYLD in macrophages (Cyld
CKO) (Figure S4A). Wild-type macro-
phages succumbed to necroptosis in
response to LPS and zVAD-fmk whereas
CKO cells survived (Figure 4A). A similar
result was observed with E. coli or
C. rodentium infection (Figure 4B). To
rule out the possibility the CYLD-deficient
BMDMs were resistant to necroptosis
due to a lack of TNF, we examined
TNF expression in the CYLD-deficient
BMDMs. Under necroptotic conditions,TNF production was slightly elevated in the CYLD-deficient mac-
rophages, arguing against defective TNF production as a reason
for their resistance to necroptosis (Figure S4B).
MLKLwas recently identified as a key effectormolecule of nec-
roptosis. It is phosphorylated by RIPK3 to form an oligomeric
structure that translocates to the plasma membrane to disrupt
membrane integrity and this can be used as a biochemical signa-
ture for necroptosis (Cai et al., 2014; Chen et al., 2014; Dondelin-
ger et al., 2014; Wang et al., 2014). TLR4 engagement in the
presence of zVAD-fmk did not lead to MLKL oligomerization in
CYLD-deficient cells (Figure 4C), demonstrating that removal of
CYLD prevents TLR4 from inducing necroptosis. Because
TLR4-induced production of TNF could potentially also activate
apoptosis, we tested to see if CYLD was involved in apoptosis.
We stimulated BMDMs with LPS after pre-treatment with cyclo-
heximide (CHX) in order to sensitize the cells to apoptosis.
Wild-type and CYLD-deficient BMDMs were equally sensitive to
apoptosis induced by LPS in the presence of cycloheximide (Fig-
ure S4C) indicating that CYLD is not required for this model of
apoptosis.Asacontrol in thisexperiment, LPS-inducednecropto-
sis was abrogated in CYLD-deficient macrophages (Figure S4C).
While removal of CYLD by CASPASE-8 will render macro-
phages resistant to necroptosis, the possibility remains that
CYLD may not be the only substrate cleaved by CASPASE-8
to block necroptosis. To test whether there may be additionaleports 15, 2449–2461, June 14, 2016 2453
Figure 4. Elimination of CYLD Protects Macrophages from TLR4-
Induced Auto-necroptosis
(A) BMDMs from Cyldflox/flox (CYLD WT) and LysM-Cre 3 Cyldflox/flox mice
(CYLD conditional knockout, or CKO) were pre-treated with DMSO or 25 mM
zVAD-fmk and stimulated with LPS for 16 hr.
(B)BMDMs fromCYLDWTorCYLDCKOwerepre-treatedwith25mMzVAD-fmk
prior to infectionwithE. coliorC. rodentium for 16 hr at the indicatedMOI. (A and
B) Cell death was analyzed as in Figure 3A. *p < 0.05, **p < 0.01, ***p < 0.001.
(C) Cyld+/+ or Cyld/ BMDMs pre-treated with 25 mM zVAD-fmk were stim-
ulated with 1 ng/ml of LPS for the indicated time. Triton-soluble lysates were
subject to non-reducing SDS-PAGE and blotted with anti-MLKL and b-actin.
The experiment shown is representative of three independent experiments.
2454 Cell Reports 15, 2449–2461, June 14, 2016CASPASE-8 substrates, we reconstituted Cyld/ BMDMs with
wild-type Cyld or the cleavage-resistant CyldD215A mutant
(O’Donnell et al., 2011) and examined whether the D215A muta-
tion negated the need for caspase inhibition. In contrast to our
previous observation in MEFs (O’Donnell et al., 2011), macro-
phages reconstituted with the cleavage-resistant CYLD-D215A
did not undergo necroptosis unless zVAD-fmk was present
(Figure S4D). This suggests that CYLD may not be the only sub-
strate cleaved by CASPASE-8 following TLR4 ligation. RIPK1 is
another necroptosis-signaling molecule that has been impli-
cated as a substrate for CASPASE-8 (Lin et al., 1999; Martinon
et al., 2000; McComb et al., 2014b). We therefore used an anti-
body raised against the N-terminal region of RIPK1 to detect
its potential cleavage. LPS stimulation induced the appearance
of several smaller fragments of RIPK1 that were abrogated in
the presence of zVAD-fmk (Figure S4E). This LPS-inducible
appearance of these RIPK1 fragments is consistent with the pos-
sibility that multiple substrates including CYLD and RIPK1 are
cleaved by CASPASE-8 when TLR4 is stimulated. Their removal
in a TRIF-dependent manner likely generates a self-preservation
signal by preventing the induction of auto-necroptosis in macro-
phages from the ongoing TNF production during an infection.
TNF-Dependent Auto-necroptosis in Macrophages Also
Requires Priming by Type I IFN
In addition to TNF production, macrophages also produce type I
interferon (IFN) following sensing of Gram-negative bacteria by
TLR4 (Doyle et al., 2002; Kawai et al., 2001). Therefore, during
this interaction between bacteria and macrophages, multiple
signaling pathways are engaged including the TLR4, TNFR,
and IFNAR pathways. How these different pathways cross-regu-
late each other to control necroptosis is unclear. There is
increasing evidence that IFNs can regulate necroptosis (Doyle
et al., 2002; Kawai et al., 2001; Robinson et al., 2012; Thapa
et al., 2013), but there are conflicting reports on the role of
type I IFN in TLR-induced necroptosis (He et al., 2011; Kaiser
et al., 2013; McComb et al., 2014a). For these reasons, we
wanted to examine whether type I IFN has any role in our low-
dose LPS model where we know that autocrine TNF is inducing
the necroptosis response. Ifnar1+/+ BMDMs succumbed to nec-
roptosis whereas Ifnar1/ BMDMs survived (Figure 5A). Similar
to Ifnar1/ BMDMs, Stat2/ BMDMs were also resistant to
low-dose LPS-induced necroptosis confirming a requirement
for type I IFN signaling in this model (Figure S5A). Infection
with E. coli orC. rodentium in the presence of zVAD-fmk similarly
induced necroptosis in Ifnar1+/+ but not in Ifnar1/BMDMs (Fig-
ure 5B). The results from Figures 3A and 5A showed a surprising
finding: necroptosis of macrophages following TLR4 ligation re-
quires downstream signaling responses generated by both TNF
and type I IFN. This raised the question of the relationship be-
tween these two cytokines and suggested that induction of nec-
roptosis by TNF itself maybe dependent on IFNa/b. To test this
directly, Ifnar1+/+ and Ifnar1/ BMDMs were stimulated with
murine TNF in the presence of zVAD-fmk. Ifnar1/ BMDMs
were resistant to necroptosis induced by TNF (Figure 5C). The
requirement for IFNa/b reveals an unappreciated pathway-
extrinsic regulation of the TNF necroptosis pathway in macro-
phages by another cytokine. IFNa/b may be functioning to
Figure 5. TLR4-Induced Auto-necroptosis
in Macrophages Also Requires Type I IFN
(A–D) Ifnar1+/+ and Ifnar1/ BMDMs were pre-
treated with 25 mM zVAD-fmk prior to stimulation
with LPS (A), viable E. coli or C. rodentium (B), or
murine TNF (C) for 24 hr. (D) Wild-type BMDMs
were treated with isotype control or 1 mg/ml of
IFNAR1 neutralizing antibody prior to stimulation
with the indicated concentrations of LPS for 24 hr.
Cell death in (A)–(D) was measured by propidium
iodide staining or by CellTiter-Glo as in Figure 3.
*p < 0.05, **p < 0.01, ***p < 0.001.
(E)Wild-type BMDMswere treated as in (D) prior to
stimulation with LPS for 24 hr. Lysates were
blotted with antibodies to phosphorylated STAT1
and total STAT1. Experiment shown is represen-
tative of at least three experiments performed
independently.directly induce necroptosis following its expression in response
to TLR4 stimulation as suggested by others (McComb et al.,
2014b) or it may have an indirect role by priming the cells to
respond to TNF. To discriminate between the two mechanisms,
we used an IFNAR1-neutralizingmonoclonal antibody previously
shown to be effective in blocking type I IFN responses (Sheehan
et al., 2006). Surprisingly, anti-IFNAR1 did not inhibit necroptosis
induced by LPS (Figure 5D) whereas it inhibited STAT1 phos-
phorylation (Figure 5E), which is known to be dependent on
IFNa/b, confirming its neutralizing function. The inability of the
neutralizing anti-IFNAR1 to block necroptosis argues against
acutely produced IFNa/b as a direct trigger of necroptosis.
Rather, the combined results from the Ifnar1/ BMDMs and
the neutralizing anti-IFNAR1 experiments are more consistent
with a licensing role for type I IFN in priming macrophages for
necroptosis.Cell RType I IFN Licenses TNF-Mediated
Necroptosis by Inducing TNFR2 and
MLKL Expression
Why TNF requires IFNAR signaling to
induce necroptosis was unclear. The
defect in the TNF necroptosis pathway
in the Ifnar1/ macrophages could be
at the level of the TNF receptors or
further downstream. Our group and
others have shown that in order for
TNFR1 to induce necroptosis, ubiquiti-
nation of RIPK1 has to be disrupted to
switch RIPK1 from a pro-survival to a
pro-death signaling molecule (Arslan
and Scheidereit, 2011; O’Donnell et al.,
2012; O’Donnell and Ting, 2011). Physio-
logically, this is achieved by the simulta-
neous ligation of TNFR1 and TNFR2
whereby TNFR2 ligation leads to the
rapid degradation of the TRAF2/cIAP1/
2 E3 ubiquitin ligase complex (Chan
and Lenardo, 2000; Fotin-Mleczek
et al., 2002; Li et al., 2002; Ruspi et al.,
2014). The loss of TRAF2/cIAP1/2 reduced RIPK1 ubiquitina-
tion, facilitating the conversion of RIPK1 to a death-signaling
molecule upon TNFR1 ligation. Consistent with this model,
TNFR2 was shown to be necessary for necroptosis in T cells
(Chan et al., 2003). Therefore, we hypothesized that there may
be a defect with TNFR2 expression in the Ifnar1/ BMDMs.
We first confirmed that TNFR2 has a role in TNF-induced nec-
roptosis in macrophages. We treated wild-type BMDMs with
either murine TNF, which binds both murine TNFR1 and
TNFR2, or with human TNF, which binds only to murine
TNFR1 (Lewis et al., 1991). Murine TNF induced necroptosis
whereas human TNF did not (Figure 6A), suggesting that ligation
of both TNFR1 and TNFR2 is needed for necroptosis. Further-
more, murine TNF was able to induce necroptosis in Tnfr2+/+
but not Tnfr2/ BMDMs (Figure 6B), confirming the require-
ment for TNFR2.eports 15, 2449–2461, June 14, 2016 2455
Figure 6. Type I IFN Licenses TNF-Mediated Necroptosis by Inducing TNFR2 and MLKL Expression
(A) Wild-type BMDMs were stimulated with indicated amounts of murine or human TNF for 24 hr in the presence of zVAD-fmk. Viability was determined by
CellTiter-Glo assays as in Figure 3C.
(B) Tnfr2+/+ and Tnfr2/ BMDMs were stimulated with murine TNF for 24 hr in the presence of zVAD-fmk. Viability was determined by CellTiter-Glo assays as in
Figure 3C.
(C) Ifnar1+/+ and Ifnar1/ BMDMs stimulated with 1 ng/ml of LPS for 24 hr were stained with a PE-conjugated anti-TNFR2. Data are representative of three
independent experiments.
(D) Necroptosis in Tnfr2+/+ and Tnfr2/ BMDMs were analyzed as in Figures 3A and 3B.
(legend continued on next page)
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While TNFR1 expression is quite ubiquitous, TNFR2 expres-
sion appears to be more restricted and is induced on macro-
phages and other hematopoietic cells upon cellular activation
(Bethea et al., 1997; de Kossodo et al., 1994; Tannenbaum
et al., 1993). We thus hypothesized that TNFR2 expression
induced by LPS stimulation is dependent on IFNa/b. Using
flow cytometry, we found that LPS induced the expression of
TNFR2 in Ifnar1+/+ but not in Ifnar1/ BMDMs (Figure 6C).
Similar to the Ifnar1/ BMDMs, TNFR2 expression was also
compromised in the Stat2/ BMDMs (Figure S5B). However,
the level of Tnfr2mRNAwas not reduced in the Stat2/BMDMs
(Figure S5C), suggesting that a STAT2-dependent gene may
regulate TNFR2 expression in a post-transcriptional manner.
To test the hypothesis that defective TNFR2 expression on
Ifnar1/ BMDMs could affect necroptosis, we compared the
sensitivity of Tnfr2+/+ and Tnfr2/ BMDMs to necroptosis
induced by LPS or bacterial infection. Consistent with our hy-
pothesis, Tnfr2/ BMDMs were more resistant to necroptosis
than Tnfr2+/+ BMDMs (Figure 6D), similar to that seen in Tnf/
BMDMs (Figure S5D).
Because IFNa/b induces a large array of genes collectively
known as IFN-inducible genes (ISG), it is possible that in addition
to TNFR2, IFNAR1 deficiency may also affect the expression of
other necroptosis molecules. Of particular interest is MLKL, the
RIPK3 kinase substrate that is essential for TNF-induced nec-
roptosis (Sun et al., 2012; Zhao et al., 2012), which was recently
shown to be an ISG (Dillon et al., 2014; Thapa et al., 2013). We
examined the protein expression level of MLKL in Ifnar1+/+ and
Ifnar1/ BMDMs after stimulation with varying doses of LPS.
In contrast to other necroptosis signaling molecules including
CYLD, RIPK1, and RIPK3, MLKL protein expression was
reduced in Ifnar1/ BMDMs (Figure 6E). Because MLKL-defi-
cient macrophages were shown to be resistant to necroptosis
(Murphy et al., 2013; Wu et al., 2013), the diminished MLKL
expression in the Ifnar1/BMDMs also likely contributes to their
resistance to necroptosis. Accordingly, MLKL oligomerization
was also severely impaired in Ifnar1/ BMDMs (Figure 6F). In
Stat2/BMDMs, the basal level of MLKLwas also reduced (Fig-
ure S6A), albeit to a lesser degree than in the Ifnar1/ BMDMs.
MLKL oligomerization was also impaired in the Stat2/ BMDMs
(Figure S6B). Consistent with Mlkl being an ISG, its mRNA level
was significantly reduced in IFNAR1 and STAT2-deficient
BMDMs (Figure S6C).
These results thus far support the model that defective TNFR2
and MLKL expression in the absence of IFNa/b priming contrib-
utes to the resistance of the Ifnar1/BMDMs to necroptosis. To
test whether TNFR2 and MLKL expression are the only defects
or whether additional defects exist, we complemented Ifnar1/
BMDMs with Tnfr2 or Mlkl. Retroviral transduction of Ifnar1/(E) Ifnar1+/+ or Ifnar1/ BMDMs were stimulated with the indicated concentration
(D1A10), RIPK1, RIPK3, MLKL, and GAPDH.
(F) Ifnar1+/+ or Ifnar1/ BMDMs were pre-treated with 25 mM zVAD-fmk and stim
analyzed as in Figure 4C. Experiments were repeated twice with similar results.
(G) Ifnar1/ BMDMs were transduced with retroviruses encoding a control pro
confirmMLKL expression. Ifnar1/BMDMs transduced with TNFR2 or MLKL we
equivalent to that of Ifnar1+/+ BMDMs stimulated with 10 ng/ml of LPS for 24 hr.
Viability was determined by CellTiter-Glo as in Figure 3C.BMDMs with Tnfr2 restored the expression of TNFR2 but was
not sufficient to reverse their resistance to necroptosis (Fig-
ure 6G). Likewise, retroviral transduction of Ifnar1/ BMDMs
with Mlkl restored their expression of MLKL but this was also
insufficient to reverse their resistance to necroptosis (Figure 6G).
Simultaneous reconstitution of Ifnar1/ BMDMs with both
TNFR2 and MLKL also failed to reverse the resistance of these
cells to necroptosis (Figure 6G). This suggests that in addition
to TNFR2 andMLKL, there are additional defects in the TNF nec-
roptosis pathway in the absence of IFNa/b priming. Nonetheless,
the reduction in TNFR2 andMLKL observed in the Ifnar1/ cells
plays a key role as evidenced by the resistance of the TNFR2 and
MLKL-deficient macrophages to necroptosis. This underscores
the critical licensing role played by type I IFN in TNF-mediated
necroptosis.
DISCUSSION
This current study shows that the determination of survival
versus death in macrophages is controlled by multiple pathways
(Figure 7). We demonstrated that TLR4 activates CASPASE-8
to proteolyze and remove CYLD. This removal is a mechanism
for protecting against necroptosis that can be triggered by
the TNF produced during an infection by Gram-negative bacte-
ria.We had previously reported the existence of an early NF-kap-
paB-independent but ubiquitin-dependent cell death checkpoint
in the TNFR1 pathway (Justus and Ting, 2015; Legarda-Addison
et al., 2009; O’Donnell et al., 2007; O’Donnell and Ting,
2010). Thus, TLR4 via its activation of CASPASE-8 sustains
this early ubiquitin-dependent checkpoint in the TNFR1 path-
way by removing the CYLD deubiquitinase. However, when
CASPASE-8 is inhibited, this early ubiquitin-dependent check-
point is disrupted and macrophages undergo auto-necroptosis
mediated by the TNF that is produced during the infection.
This process occurs in a cell-autonomous manner, likely medi-
ated by a ligand-receptor interaction in cis. This auto-necropto-
sis response further requires licensing by type I IFN, which is
necessary for the expression of TNFR2, MLKL, and potentially
other necroptosis-signaling molecules. In the absence of
TNFR2 and MLKL, the ability of TNF to induce necroptosis is
severely compromised. Our data thus demonstrates an unap-
preciated pathway-extrinsic regulation of the TNF necroptosis
pathway by the TLR4 and type I IFN receptors in a negative
and positive manner, respectively.
We previously demonstrated that whether CYLD is cleaved
by CASPASE-8 or not is the key determinant of survival versus
necroptotic death in MEFs following TNFR1 ligation (O’Donnell
et al., 2011). Our current study demonstrates that TLR4, in a
TRIF-dependent mechanism, activates CASPASE-8 to removes of LPS for 4 hr. Triton-soluble lysates were blotted with antibodies for CYLD
ulated with 10 ng/ml of LPS for the indicated times. MLKL oligomerization was
tein, TNFR2, or MLKL, as indicated. Lysates from these cells were blotted to
re stained with PE-conjugated anti-TNFR2 to confirm TNFR2 expression that is
These cells were stimulated with LPS in the presence of 25 mM of zVAD-fmk.
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Figure 7. Regulation of Survival and Nec-
roptosis in Macrophages
During an infection, the determination of TNF-
induced necroptosis is subject to cross-regulation
by other receptor pathways. I: TLR4 activates
CASPASE-8 through a TRIF-dependent manner
to proteolyze and remove CYLD. CYLD is
essential for TNF-induced necroptosis, and its
removal prevents macrophages from undergoing
necroptosis that can be induced by the TNF
produced during bacterial infection. II: inhibition
of CASPASE-8 stabilizes CYLD and this results
in necroptosis mediated by auto-produced
TNF signaling via CYLD. Type I IFN plays a
licensing role because it is required for the induc-
tion of TNFR2, MLKL and other uncharacterized
molecules that are essential for TNF-mediated
necroptosis.CYLD and this has an inhibitory effect on the TNF death pathway.
We have genetically defined some of requirements for the cleav-
age of CYLD: it requires TRIF, RIPK1, FADD, and CASPASE-8.
An interaction between TRIF and CASPASE-8 has been sug-
gested previously (Estornes et al., 2012; Maelfait et al., 2008).
Indeed, the two molecules can interact in co-transfection ex-
periments. Alternatively, TRIF can interact with RIPK1 in a
RHIM-dependent manner (Kaiser and Offermann, 2005; Meylan
et al., 2004) and in turn, RIPK1 can recruit CASPASE-8 (Wang
et al., 2008). Therefore, it is likely that TRIF, RIPK1, FADD, and
CASPASE-8 form a proteolytic complex that confers cell survival
when macrophages are activated. This remains to be directly
confirmed because the analysis of endogenous TRIF-containing
complexes in primary macrophages has been hampered by the
lack of suitable immunoprecipitating antibodies against TRIF.
Our current analysis of how TLR4 regulates CYLD cleavage in
macrophages has revealed a couple of aspects that are different
from our previous analysis of CYLD cleavage in MEFs. While
RIPK1 was not required for CYLD cleavage in response to
TNFR1 ligation in MEFs (O’Donnell et al., 2011), it appears to
have a role in the TLR4-induced response in macrophages, in
part by regulating the expression of CASPASE-8 itself, or
RIPK1 could also serve to recruit CASPASE-8 to TRIF. Another
differing aspect is that we did not detect any RIPK1 cleavage
in response to TNFR1 stimulation in MEFs whereas this was
observed in response to TLR4. In conjunction, mutating the
cleavage site of CYLD was sufficient to sensitize MEFs to un-
dergo TNF-induced necroptosis and negating the need for cas-
pase inhibition, whereas this was insufficient in macrophages.
Thus, multiple substrates may be cleaved by CASPASE-8 in
macrophages following TLR4 stimulation, indicating receptor
and cell type differences in the regulation of CYLD cleavage.
While TNF is not required for the CYLD cleavage observed
upon TLR4 stimulation, it is required for the necroptosis induced2458 Cell Reports 15, 2449–2461, June 14, 2016upon caspase inhibition. Our result differs
from previous studies suggesting that
TNF is not required (He et al., 2011; Kaiser
et al., 2013; McComb et al., 2014a; Rob-
inson et al., 2012) and this is likely due to
the low doses of LPS used in the current study compared to the
high doses used in the previous studies. We further confirmed
that the LPS results were reflective of that seen during bacterial
infection by infecting macrophages with a low MOI of viable
C. rodentium and E. coli. The genetic requirement for a molecule
in a TLR pathway could be missed when higher doses of ligand
are utilized as illustrated by Bonham et al. (2014) in their study of
the adaptor molecule TIRAP in TLR9 signaling. Surprisingly, we
were unable to block this TNF-dependent death process using
a soluble TNFR1-Fc antagonist indicating that this is not medi-
ated by secreted TNF. Instead, this observation strongly sug-
gests that TNF is engaging its receptors within the cell and acti-
vating downstream signaling in a cell-autonomous manner. The
biological reason for why macrophages are wired to undergo
auto-necroptosis upon caspase inhibition is unclear. We specu-
late that this may serve a tripwire function in a sentinel cell such
as a macrophage where pathogen or host-mediated alterations
in caspase activity following an infection could trigger necropto-
sis as a danger signal.
In contrast to the inhibitory effect TLR4 exerts on the TNF nec-
roptosis pathway, type I IFN receptor signaling exerts a positive
effect on this death pathway in a STAT2-dependent manner. Our
analysis unequivocally showed that LPS- and TNF-induced nec-
roptosis required IFNa/b-mediated responses. This requirement
for type I IFN in order for TNF to trigger necroptosis was quite un-
expected and prompted us to examine the basis of this cross-
talk. We initially directed our attention at TNFR2 and found that
its expression after LPS stimulation was impaired in the Ifnar1/
macrophages and it is required for necroptosis to occur. In addi-
tion to TNFR2, expression of MLKL was also reduced in the
Ifnar1/ BMDMs. There are likely additional defects in the
Ifnar1/ cells, as reconstitution with Tnfr2 and Mlkl did not
reverse their resistance to death. Because the other molecules
essential for TNF necroptosis described to date (CYLD, RIPK1,
and RIPK3) are present in the Ifnar1/ BMDMs, it is likely other
molecules essential for necroptosis remain to be characterized.
The requirement for IFNAR1 raises the question whether
IFNa/b produced following sensing of microbes directly induces
necroptosis, as suggested by a recent report (McComb et al.,
2014a), or whether basal level of IFNa/b in BMDMs cultures
prime these cells to respond to TNF. Our finding that a neutral-
izing anti-IFNAR1 did not inhibit necroptosis of BMDMs indicates
that the IFNa/b acutely produced in response to LPS does
not directly trigger necroptosis. Rather, prior exposure of the
BMDMs to IFNa/b is necessary to license and prime the necrop-
tosis pathway via the induction of essential signaling molecules.
The requirement of IFNAR1 as an essential regulator for necrop-
tosis is likely restricted to certain cell types as suggested by
genetic crosses involving the Casp8/ mice. The embryonic
lethality of Casp8/ mice was rescued by crossing the mice
to Ripk3/ mice (Kaiser et al., 2011; Oberst et al., 2011) but
not by crossing to Stat1/ mice that are defective in type I IFN
signaling (Thapa et al., 2013), indicating that the necroptosis
pathway in the cell type affected in the Casp8/ embryos is
not dependent on IFN signaling. A report by Duprez et al.
(2011) demonstrated that RIPK3-dependent necroptosis was
responsible for the morbidity and mortality in a mouse model
of sterile sepsis induced by TNF. Prior to the study by Duprez
et al. (2011), Huys et al. (2009), using a similar model of TNF-
induced sepsis, showed that IFNAR1 was essential for driving
this disease, further indicating that the interplay of type I IFN
and TNF is relevant in vivo.
In summary, our studies showed that necroptosis of macro-
phages is regulated in a complex manner by multiple crosstalk
between the TLR4, TNF, and IFN receptors and highlights the in-
sights gained from studying the TNF death pathway in the
context of other pathways that are concurrently activated.
EXPERIMENTAL PROCEDURES
Generation of CYLD Conditional Knockout Mice
Mice expressing loxP-flanked (floxed) Cyld exon 8 and 9 were generated by
Ingenious Targeting Laboratories. These mice were backcrossed to C57BL/
6 for ten generations and were then crossed with LysM-Cre transgenic mice,
which express the Cre recombinase from a myeloid-specific promoter, to
selectively delete CYLD from monocytes and macrophages (LysM-Cre Cy-
ldflox/flox, or CYLD conditional knockout, or CYLD CKO). For all experiments
performed, Cyldflox/flox littermates were used as controls (CYLD WT).
Bone Marrow-Derived Macrophages
Bone marrow-derived macrophages (BMDMs) were generated by culturing
bone marrow progenitors in L929 conditioned medium. Immortalization of
BMDM from Ripk1 conditional knockouts was conducted by infection with
J2 oncovirus (Roberson and Walker, 1988).
Cell Death Assays
Cell death was analyzed by propidium iodide staining followed by flow cytom-
etry or with the CellTiter-Glo Luminescent Cell Viability Assay kit (Promega).
Western Blot Analysis
Cellular lysates obtained using 1% Triton X-100 were resolved by reducing
SDS-PAGE. For MLKL oligomerization, lysates generated using either 2%
SDS orM2 buffer containing 1%Triton X-100were resolved by SDS-PAGE un-
der non-reducing conditions (without beta-mercaptoethanol). Blotting was
conducted with standard techniques.Statistical Analysis
Cell death, cell viability, and intracellular staining data are presented as the
mean ± SD. Statistics were performed using t test (*p < 0.05, **p < 0.01,
***p < 0.001). Real-time qPCR data are presented as the mean ± SD. Statistics
were performed using two-way ANOVA. Bonferroni post-tests were performed
to compare the triplicate means at different time points (**p < 0.01, ***p <
0.001).
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